Search Saint Luke's

Metastatic Cancer
An Open-Label, Randomized, Controlled Phase 3 Study of Sigvotatug Vedotin in Combination with Pembrolizumab Compared with Pembrolizumab Monotherapy as First-Line Treatment in Participants with PD-L1 High (≥50% of Tumor Cells Expressing PD-L1), Locally Advanced, Unresectable, or Metastatic Non-Small Cell Lung Cancer

Lung Cancer
An Open-Label, Randomized, Controlled Phase 3 Study of Sigvotatug Vedotin in Combination with Pembrolizumab Compared with Pembrolizumab Monotherapy as First-Line Treatment in Participants with PD-L1 High (≥50% of Tumor Cells Expressing PD-L1), Locally Advanced, Unresectable, or Metastatic Non-Small Cell Lung Cancer (SigVie-003). 

Saint Luke's is proud to deliver nationally recognized stroke care. Saint Luke's Hospital of Kansas City has consistently earned several prestigious honors for stroke care.

In 1882, Saint Luke’s was a small hospital serving a frontier trading town. Today, we are an integrated system of 14 hospitals and campuses with more than 12,000 employees caring for a metropolitan area of two million people, and our service area spans 67 counties in Missouri and Kansas.

David counted on the team of experts at Saint Luke's Cancer Institute and Saint Luke's Hospital Center for Precision Oncology throughout his health care journey from an incurable diagnosis to now in complete remission.

Saint Luke’s is a member of Missouri Health Connection (MHC) which is the state-wide Health Information Exchange. Saint Luke’s is participating with MHC to provide a HIPAA compliant, secure and encrypted email platform called MHC CareMail or more commonly known as Direct.

View a list of Saint Luke's doctors' offices insurance plans.

This Notice serves as a joint notice for BJC Health affiliated hospitals, facilities, and providers and Washington University School of Medicine (collectively referred to herein as “we” or “our” or “us”) of our privacy practices related to health information.